Showing results (1021-1030 of 1,547) with videos related to

Sort By:
Pageof 155
Cancer|August 27, 2015
Multicenter phase 2 study of patupilone for recurrent or progressive brain metastases from non-small cell lung cancerLakshmi Nayak, Lisa M DeAngelis, H Ian Robins, et al.
Breast Cancer Research and Treatment|March 28, 2023
Metaplastic carcinoma of the breast: matched cohort analysis of recurrence and survivalPriyanka Narayan, Caroline E Kostrzewa, Zhigang Zhang, et al.
Targeted Oncology|January 25, 2013
Cytokines associated with toxicity in the treatment of recurrent glioblastoma with afliberceptNicole Shonka, Yuji Piao, Mark Gilbert, et al.
Neuro-Oncology Advances|August 19, 2021
Analysis of morphological characteristics of IDH-mutant/wildtype brain tumors using whole-lesion phenotype analysisJames M Snyder, Raymond Y Huang, Harrison Bai, et al.
Investigational New Drugs|April 28, 2019
Clinical pharmacokinetics and pharmacodynamics of ivosidenib, an oral, targeted inhibitor of mutant IDH1, in patients with advanced solid tumorsBin Fan, Ingo K Mellinghoff, Patrick Y Wen, et al.
Nature Communications|September 27, 2019
Chromatin-informed inference of transcriptional programs in gynecologic and basal breast cancersHatice U Osmanbeyoglu, Fumiko Shimizu, Angela Rynne-Vidal, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 31, 2013
Clinical and epidemiological survey and analysis of the first case of human infection with avian influenza A(H7N9) virus in Hangzhou, ChinaL Xie, H Ding, Q-J Kao, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2022
Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket studyV Subbiah, R J Kreitman, Z A Wainberg, et al.
NPJ Breast Cancer|June 19, 2020
Pleomorphic adenomas and mucoepidermoid carcinomas of the breast are underpinned by fusion genesFresia Pareja, Arnaud Da Cruz Paula, Rodrigo Gularte-Mérida, et al.
Neuro-Oncology|January 25, 2023
Telomerase inhibition is an effective therapeutic strategy in TERT promoter-mutant glioblastoma models with low tumor volumeElisa Aquilanti, Lauren Kageler, Jacqueline Watson, et al.
Pageof 155